Evaluation of oncogenic human papillomavirus RNA and DNA tests with liquid-based cytology in primary cervical cancer screening: The FASE study-Reference-Cited by-同舟云学术

Evaluation of oncogenic human papillomavirus RNA and DNA tests with liquid-based cytology in primary cervical cancer screening: The FASE study

Published:2010-12-08 Issue:3 Volume:129 Page:691-701
ISSN:0020-7136
Container-title:International Journal of Cancer
language:en
Short-container-title:Int. J. Cancer

Author:

Monsonego Joseph,Hudgens Michael G.,Zerat Laurent,Zerat Jean-Claude,Syrjänen Kari,Halfon Philippe,Ruiz Fabrice,Smith Jennifer S.

Publisher

Wiley

Subject

Cancer Research,Oncology

Reference44 articles.

1. New developments in cervical cancer screening and prevention. Geneva, Switzerland, June 17-19, 1996 Workshop;Franco;Cancer Epidemiol Biomarkers Prev,1996

2. Report on consensus conference on cervical cancer screening and management;Miller;Int J Cancer,2000

3. Performance of the Roche Amplicor human papillomavirus (HPV) test in prediction of cervical intraepithelial neoplasia (CIN) in women with abnormal PAP smear;Monsonego;Gynecol Oncol,2005

4. Reproducibility of classification and correction for verification bias as determinants of performance of Papanicolaou smear cytology in the screening setting: Experience from the New Independent States of the former Soviet Union cohort study;Syrjänen;Acta Cytologica,2009

Cited by 122 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The level of expression of HPV16 early transcripts is not associated with the natural history of cervical lesions;Journal of Medical Virology;2024-09

2. RNA extended interventional nucleic acid longitudinal study: Clinical performance of Aptima messenger RNA HPV testing in cervical cancer screening with a 9‐year follow‐up;Cancer Cytopathology;2024-08-19

3. Screening for the prevention and early detection of cervical cancer: systematic reviews to inform an update to recommendations by the Canadian Task Force on Preventive Health Care;2024-08-09

4. HPV18 E6/E7 activates Ca²⁺ influx to promote the malignant progression of cervical cancer by inhibiting Ca²⁺ binding protein 1 expression;Biotechnology and Applied Biochemistry;2024-08-07

5. Liquid-based Cytology as a Superior Tool Compared to Conventional Pap Smear in Detecting Cervical Cancer in Suspected Cases: A Comparative Study;Advances in Human Biology;2024-02-20